DNAnexus

From sequence to structure—faster. Protein structure prediction is foundational to modern drug discovery, but running state-of-the-art methods often means managing massive reference databases, complex environments, and specialized compute. The solution? Introducing the DNAnexus Molecular Modeling Accelerator. It brings validated nf-core/proteinfold workflows, preconfigured environments, and scalable compute together in one place—so teams can focus on modeling, not setup. Designed to support AlphaFold2 and related methods, it’s ready to run on the DNAnexus platform, with GPU support when needed. Less setup. More science. Swipe through to see what’s available. 👉 Ready for your analysis? Get started at: https://lnkd.in/g8ecv4d3

Regeneron has been a trusted partner and collaborator for over ten years. They saw that the future of genomics research was cloud-based, as researchers needed a secure way to manage and analyze increasingly complex datasets. Together we've enabled a growing community of global healthcare researchers to unify disparate datasets, perform multiomics research at scale, and accelerate their time to insights. Read more below about our collaboration 👇 #RegneronGeneticsCenter #Genomics #MultiOmics #PrecisionMedicine

Join us for Mithrls #JPM26 satellite event on Pharma’s AI-Accelerated Future! Mia Nease, DBA, DNAnexus SVP of US Sales, will speak alongside other visionaries from the pharma, biotech, and AI industries to the next wave of therapeutic discovery. Register now: https://hubs.ly/Q03-BYZ-0 #Pharma #AI #DrugDevelopment #DrugDiscovery

We’re excited to join the Slalom Healthcare & Life Sciences roundtable today at #JPM26 alongside leaders from OpenAI & Snowflake. DNAnexus VP of Regulatory Technology Innovation Jimita Parekh will join the roundtable to discuss how we’re streamlining the drug review process with our AI-enabled cloud-based regulatory platform. #PharmaInnovation #RegulatoryScience #AI #RegulatoryTransformation

The shift from "AI hype" to "Frontier AI" in drug discovery requires more than just algorithms—it requires a foundation of secure, scalable data. We’re proud to see our CEO, Thomas Laur, joining an incredible lineup of leaders from Bain Capital, Johnson & Johnson, Terray Therapeutics, and more at the AI in Healthcare Summit this Wednesday. As the industry gathers for #JPM26, we’re focused on the "how" - enabling the models that will deliver the next generation of therapeutics. Read the full update below. #innovation #leadership #precisionhealth #precisionmedicine

A brand new publication was just released on ScienceDirect regarding ADAPT, the program from ARPA-H to revolutionize personalized cancer care. We’re proud to support their mission by building the ADAPT Treatment and Analysis Platform (TAP), an informatics platform that serves as a unified resource for the initiative's multimodal biomarker discovery. TAP integrates patient data and evolutionary trial protocols to serve as the ADAPT drug development engine. ADAPT researchers are able to use TAP to design, test, and standardize newly developed biomarkers and drug targets. Learn more about this important nationwide initiative: https://hubs.ly/Q03-cncH0 #ADAPT #ARPAH #PrecisionOncology #CancerCare #HealthTech #precisionmedicine #populationhealth

Kickstart your 2026 drug discovery goals by learning how to leverage the Tahoe-100M single-cell dataset in your analysis pipelines: https://hubs.ly/Q03ZYJly0 Our on demand webinar will take you through how to access the largest single-cell dataset of its kind natively on DNAnexus. We provide step-by-step instructions to achieve faster, de-risked hit-to-lead and build more predictive AI models by collaborating in secure, governed joint workspaces. #SingleCell #DrugDiscovery #AI #Biomarkers #PopulationHealth #PrecisionMedicine

Join experts from Myriad Genetics and PacBio as they walk through their collaboration to enhance prenatal carrier screening for challenging genetic conditions, with the computational workflow hosted on DNAnexus. Attendees will see how their computational workflow leverages PacBio PureTarget long-read sequencing assay to resolve difficult genetic structural variations and improve the accuracy of Myriad’s Foresight® Carrier Screen. Register now: https://hubs.ly/Q03ZzGLK0 #Diagnostics #Genetics #StructuralVariants #PacBio #MyriadGenetics #PrenatalScreening #precisionmedicine

Happy New Year! We hope you’ve had a restful Holiday season as you prepare for the year ahead. We’ve got ambitious plans for 2026 that we’ve been working tirelessly on in the background and we can’t wait to unveil them. Keep your eyes peeled for exciting news coming from us soon 👀 Follow us for updates and join our monthly newsletter: https://hubs.ly/Q03YKLXt0. #NewYear #GoalSetting #PrecisionHealth

Easily explore, review and manage your data in one secure environment. Omics Data Catalog makes multimodal datasets easy to discover, reuse, and govern through centralized and structured data management. Data Review Board enables users to deliver specific datasets and analysis tools to data stakeholders in the secure data environment. Utilize project level controls to keep data and workflows secure. Request a demo today: https://hubs.ly/Q03YKYHk0 #Genomics #Multiomics #DataManagement #DataDiscovery #CloudPlatform